Pfizer Inc: Form 10-K for the period ended Dec 31, 2017
Filed with the SEC on Feb 22, 2018 and accepted by EDGAR at Feb 22, 2018, 20:42 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Selling, general and administrative | 12 months2017-01-01 to 2017-12-31 | $14.78bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 12 months2017-01-01 to 2017-12-31 | $1.27bn | us-gaap:InterestExpense |
| Income tax | 12 months2017-01-01 to 2017-12-31 | −$9.05bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2017-01-01 to 2017-12-31 | $21.31bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2017-01-01 to 2017-12-31 | $3.52 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2017-01-01 to 2017-12-31 | $3.57 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2017-01-01 to 2017-12-31 | 6,058,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2017-01-01 to 2017-12-31 | $16.47bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2017-01-01 to 2017-12-31 | $1.96bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2017-01-01 to 2017-12-31 | $5.00bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-12-31 | $1.34bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-12-31 | $41.14bn | us-gaap:AssetsCurrent |
| Total assets | At period end2017-12-31 | $171.80bn | us-gaap:Assets |
| Current liabilities | At period end2017-12-31 | $30.43bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-12-31 | $100.14bn | us-gaap:Liabilities |
| Long-term debt | At period end2017-12-31 | $33.54bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2017-12-31 | $3.55bn | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2017-12-31 | $6.10bn | us-gaap:CommercialPaper |
| Shareholders' equity | At period end2017-12-31 | $71.31bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000078003-18-000027. Last ingested by Listed: Nov 12, 2026, 18:08 ET. Listed shows no prices and gives no investment advice.